Search

Your search keyword '"García-Retortillo, Montserrat"' showing total 148 results

Search Constraints

Start Over You searched for: Author "García-Retortillo, Montserrat" Remove constraint Author: "García-Retortillo, Montserrat"
148 results on '"García-Retortillo, Montserrat"'

Search Results

1. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

2. Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

4. Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.

5. FRI-051 Differences between urgent and electivemajor surgery in patients with advanced chronic liver disease and discriminatory capacity of the VOCAL-Penn

6. TOP-149-YI Plasmatic expression of miR122-5p and miR21-5p predicts relapse of autoimmune hepatitis after treatment withdrawal

7. THU-155 Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study

8. THU-170-YI Paris II criteria are better than Poise to predict liver-related complications after second line therapy in patients with primary biliary cholangitis

9. THU-154-YI Diabetes mellitus (DM) is associated with worse outcomes in patients with primary biliary cholangitis (PBC) regardless of the presence of liver steatosis: results from the ColHai registry

10. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

12. Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statements

13. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study

14. Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry

15. Further decompensation as a new prognostic stage in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements

16. Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

17. Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)

18. Analysis of surgical risk in patients with advanced chronic liver disease and major orthopedic surgery from a gender perspective

19. Characterizing chronic hepatitis delta in Spain and the gaps in its management

20. Acute kidney injury related to metamizole in advanced chronic liver disease patients undergoing major orthopedic surgery

22. A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C

25. Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity

26. LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

27. THU-118 Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study

28. THU-189 Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry

30. Noninvasive Prediction of Outcomes in Autoimmune Hepatitis–Related Cirrhosis

35. WED-166 - Characterizing chronic hepatitis delta in Spain and the gaps in its management

36. WED-300 - Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)

37. WED-270 - Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies

38. WED-264 - Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry

41. LBP-09 - Further decompensation as a new prognostic stage in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements

45. FRI384 - Changing HCV patient profiles: insights from a large multinational real-world sofosbuvir/velpatasvir (SOF/VEL) dataset

46. THU482 - Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry

48. FRI-039-Autoimmune hepatitis-related cirrhosis: The importance of treatment response and the utility of Baveno VI criteria

50. Correction: Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

Catalog

Books, media, physical & digital resources